Provided by Tiger Fintech (Singapore) Pte. Ltd.

MindWalk Holdings Corp

1.87
+0.260016.15%
Post-market: 1.84-0.0300-1.60%19:02 EDT
Volume:1.13M
Turnover:2.05M
Market Cap:86.31M
PE:-3.38
High:1.93
Open:1.63
Low:1.62
Close:1.61
52wk High:3.25
52wk Low:0.2700
Shares:46.15M
Float Shares:41.95M
Volume Ratio:2.92
T/O Rate:2.69%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5531
EPS(LYR):-0.6554
ROE:-112.36%
ROA:-14.57%
PB:5.85
PE(LYR):-2.85

Loading ...

MindWalk director Kamil Isaev resigns after failing to get majority vote

TIPRANKS
·
Oct 21

MindWalk appoints R. Scott Areglado as Chief Financial Officer

TIPRANKS
·
Oct 21

BRIEF-MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy

Reuters
·
Oct 21

MindWalk Holdings Corp. Appoints Dr. Thomas W. Lynch as Chief Business Officer to Drive Global Expansion

Reuters
·
Oct 15

Mindwalk Appoints DR. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion

THOMSON REUTERS
·
Oct 15

MindWalk Approves Stock Buyback Plan

MT Newswires Live
·
Oct 09

Mindwalk Holdings Corp - to Repurchase up to 2.3 Mln Shares of Co

THOMSON REUTERS
·
Oct 09

Mindwalk Announces Share Repurchase Program

THOMSON REUTERS
·
Oct 09

BRIEF-MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity

Reuters
·
Sep 22

MindWalk Holdings Corp. Unveils AI-Driven Dual-Pathway GLP-1 Regimen for Aging and Longevity, Targeting $60B Market

Reuters
·
Sep 22

Mindwalk Advances AI-Designed Glp-1 Program With First-in-Class Dual-Pathway Regimen for Aging and Longevity

THOMSON REUTERS
·
Sep 22

MindWalk Holdings Corp. Reports 45% Increase in Quarterly Revenue, Narrows Net Loss to $3.0 Million

Reuters
·
Sep 15

Mindwalk Holdings Corp.™ (Formerly Immunoprecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet

THOMSON REUTERS
·
Sep 15

Press Release: MindWalk Holdings Corp.(TM) (formerly ImmunoPrecise Antibodies(TM)) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet

Dow Jones
·
Sep 15

MindWalk Holdings Corp. Announces Date for Annual General Meeting via Webcast

Reuters
·
Sep 13

MindWalk Holdings Corp expected to post a loss of 5 cents a share - Earnings Preview

Reuters
·
Sep 12

Press Release: MindWalk to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2026 on September 15, 2025

Dow Jones
·
Sep 10

MindWalk Holdings Corp. to Announce Financial Results for First Quarter Fiscal Year 2026

Reuters
·
Sep 10

BRIEF-Immunoprecise Rebrands As Mindwalk, Announces Nasdaq Ticker Change To “Hyft”

Reuters
·
Sep 03

Immunoprecise Rebrands as Mindwalk, Announces Nasdaq Ticker Change to “Hyft”

THOMSON REUTERS
·
Sep 03